Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
European Journal of Neurology2015Vol. 23(1), pp. 45–52
Citations Over TimeTop 10% of 2015 papers
Antonio Emanuele Elia, Stefania Lalli, Maria Rosaria Monsurrò, Anna Sagnelli, Alfonsa Claudia Taiello, B. Reggiori, Vincenzo La Bella, G. Tedeschi, Alberto Albanese
Abstract
This pilot study provides preliminary clinical data indicating that TUDCA is safe and may be effective in ALS.
Related Papers
- → A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis(1994)2,177 cited
- → Dose-ranging study of riluzole in amyotrophic lateral sclerosis(1996)1,285 cited
- → An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole(1998)197 cited
- → Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151)(2012)
- → Faculty Opinions recommendation of Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.(2011)